Nur Hani Zainal1, Michelle G Newman2. 1. The Pennsylvania State University, United States. Electronic address: nvz5057@psu.edu. 2. The Pennsylvania State University, United States.
Abstract
INTRODUCTION: Scar theories propose that elevated depression and anxiety can predispose people to future decreased executive function (EF) via heightened inflammation across decades. However, more longitudinal (versus cross-sectional) research on this topic is needed. OBJECTIVE: We thus investigated if increased major depressive disorder (MDD), generalized anxiety disorder (GAD), and panic disorder (PD) severity predicted EF decrement 18 years later via heightened inflammation. METHOD: Community-dwelling adults participated in this study. Time 1 (T1) MDD, GAD, and PD severity (Composite International Diagnostic Interview-Short Form), T2 inflammation (interleukin-6, C-reactive protein, and fibrinogen blood levels concentration), and T2 and T3 EF (Brief Test of Adult Cognition by Telephone) were measured. The waves of assessment were spaced approximately 9 years apart. Structural equation modeling was conducted. RESULTS: Higher T1 MDD and GAD (but not PD) severity forecasted elevated T2 inflammation (Cohen's d = 0.116-0.758). Greater T2 inflammation level predicted lower T3 EF following 9 years (d = -0.782--0.636). The T1 MDD-T3 EF and T1 GAD-T3 EF negative associations were mediated by T2 inflammation, and explained 38% and 19% of the relations, respectively. Direct effects of higher T1 GAD and MDD predicting lower T3 EF were also observed (d = -0.585--0.560). Significant effects remained after controlling for socio-demographic, lifestyle, medication use, various illness variables across time, and T2 EF. CONCLUSIONS: Inflammation may be a mechanism explaining the T1 MDD-T3 EF and T1 GAD-T3 EF relations. Treatments that target inflammation, worry, and/or depression may prevent future EF decline.
INTRODUCTION: Scar theories propose that elevated depression and anxiety can predispose people to future decreased executive function (EF) via heightened inflammation across decades. However, more longitudinal (versus cross-sectional) research on this topic is needed. OBJECTIVE: We thus investigated if increased major depressive disorder (MDD), generalized anxiety disorder (GAD), and panic disorder (PD) severity predicted EF decrement 18 years later via heightened inflammation. METHOD: Community-dwelling adults participated in this study. Time 1 (T1) MDD, GAD, and PD severity (Composite International Diagnostic Interview-Short Form), T2 inflammation (interleukin-6, C-reactive protein, and fibrinogen blood levels concentration), and T2 and T3 EF (Brief Test of Adult Cognition by Telephone) were measured. The waves of assessment were spaced approximately 9 years apart. Structural equation modeling was conducted. RESULTS: Higher T1 MDD and GAD (but not PD) severity forecasted elevated T2 inflammation (Cohen's d = 0.116-0.758). Greater T2 inflammation level predicted lower T3 EF following 9 years (d = -0.782--0.636). The T1 MDD-T3 EF and T1 GAD-T3 EF negative associations were mediated by T2 inflammation, and explained 38% and 19% of the relations, respectively. Direct effects of higher T1 GAD and MDD predicting lower T3 EF were also observed (d = -0.585--0.560). Significant effects remained after controlling for socio-demographic, lifestyle, medication use, various illness variables across time, and T2 EF. CONCLUSIONS: Inflammation may be a mechanism explaining the T1 MDD-T3 EF and T1 GAD-T3 EF relations. Treatments that target inflammation, worry, and/or depression may prevent future EF decline.
Authors: Mary A Whooley; Catherine M Caska; Bethany E Hendrickson; Meghan A Rourke; Joseph Ho; Sadia Ali Journal: Biol Psychiatry Date: 2007-04-16 Impact factor: 13.382
Authors: Karen A Matthews; Laura L Schott; Joyce Bromberger; Jill Cyranowski; Susan A Everson-Rose; Mary Fran Sowers Journal: Psychosom Med Date: 2007-02-08 Impact factor: 4.312
Authors: Ana Belén Fernández-Serrano; Francisco José Moya-Faz; Cesar Augusto Giner Alegría; Juan Carlos Fernández Rodríguez Journal: Brain Behav Date: 2022-05-19 Impact factor: 3.405